The company’s current portfolio consists of 102 products authorises for distribution in US marketplace and 64 ANDA’s pending approval with the USFDA.
Subscribe To Our Free Newsletter |
The company’s current portfolio consists of 102 products authorises for distribution in US marketplace and 64 ANDA’s pending approval with the USFDA.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!